NASDAQ

Amplitech Group, Inc. - Series B Right (AMPGZ)

390 Thanks from members

AmpliTech Group (AMPGZ) faces mixed sentiment, moving from a disappointing Q1 2026 EPS miss (-$0.06 vs -$0.051) and share selloffs toward a potentially dramatic operational recovery, highlighted by Q2 2026 revenue of $8.07M and surging gross margins.

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →